1. Home
  2. THRD vs SBXD Comparison

THRD vs SBXD Comparison

Compare THRD & SBXD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRD
  • SBXD
  • Stock Information
  • Founded
  • THRD 2019
  • SBXD 2024
  • Country
  • THRD United States
  • SBXD United States
  • Employees
  • THRD N/A
  • SBXD N/A
  • Industry
  • THRD Biotechnology: Pharmaceutical Preparations
  • SBXD
  • Sector
  • THRD Health Care
  • SBXD
  • Exchange
  • THRD Nasdaq
  • SBXD NYSE
  • Market Cap
  • THRD 238.7M
  • SBXD 257.1M
  • IPO Year
  • THRD 2022
  • SBXD 2024
  • Fundamental
  • Price
  • THRD $5.46
  • SBXD $10.63
  • Analyst Decision
  • THRD Hold
  • SBXD
  • Analyst Count
  • THRD 3
  • SBXD 0
  • Target Price
  • THRD $5.00
  • SBXD N/A
  • AVG Volume (30 Days)
  • THRD 220.4K
  • SBXD 187.4K
  • Earning Date
  • THRD 08-07-2025
  • SBXD 01-01-0001
  • Dividend Yield
  • THRD N/A
  • SBXD N/A
  • EPS Growth
  • THRD N/A
  • SBXD N/A
  • EPS
  • THRD N/A
  • SBXD N/A
  • Revenue
  • THRD N/A
  • SBXD N/A
  • Revenue This Year
  • THRD N/A
  • SBXD N/A
  • Revenue Next Year
  • THRD N/A
  • SBXD N/A
  • P/E Ratio
  • THRD N/A
  • SBXD $52.08
  • Revenue Growth
  • THRD N/A
  • SBXD N/A
  • 52 Week Low
  • THRD $3.18
  • SBXD $9.95
  • 52 Week High
  • THRD $16.02
  • SBXD $11.64
  • Technical
  • Relative Strength Index (RSI)
  • THRD 66.73
  • SBXD N/A
  • Support Level
  • THRD $5.42
  • SBXD N/A
  • Resistance Level
  • THRD $5.45
  • SBXD N/A
  • Average True Range (ATR)
  • THRD 0.04
  • SBXD 0.00
  • MACD
  • THRD -0.01
  • SBXD 0.00
  • Stochastic Oscillator
  • THRD 50.00
  • SBXD 0.00

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

About SBXD SILVERBOX CORP IV

SilverBox Corp IV is a blank check company.

Share on Social Networks: